These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9829629)

  • 21. Monoamine metabolite concentrations in the cerebrospinal fluid of normal and narcoleptic dogs.
    Faull KF; Barchas JD; Foutz AS; Dement WC; Holman RB
    Brain Res; 1982 Jun; 242(1):137-43. PubMed ID: 6179569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease.
    Poceta JS; Parsons L; Engelland S; Kripke DF
    Sleep Med; 2009 Jan; 10(1):129-33. PubMed ID: 18207455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoamine compounds in cerebrospinal fluid of healthy subjects punctured without preceding strict bed rest: a pilot study.
    Eklundh T; Gunnarsson T; Nordin C
    Neuropsychobiology; 2001 Jan; 43(1):5-10. PubMed ID: 11150891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses.
    Lappalainen J; Long JC; Virkkunen M; Ozaki N; Goldman D; Linnoila M
    Biol Psychiatry; 1999 Sep; 46(6):821-6. PubMed ID: 10494451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in monoamine metabolites concentrations in rat cerebrospinal fluid after acute and long-term administration of a selective serotonin reuptake inhibitor, trazodone.
    Egashira T; Takayama F; Yamanaka Y
    Pharmacol Res; 1999 Dec; 40(6):503-8. PubMed ID: 10660949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Free and conjugated amines in human lumbar cerebrospinal fluid.
    Tyce GM; Rorie DK; Byer DE; Danielson DR
    J Neurochem; 1985 Jan; 44(1):322-4. PubMed ID: 2578061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoamines in the brain cerebrospinal fluid of facial pain patients.
    Bouckoms AJ; Sweet WH; Poletti C; Lavori P; Carr D; Matson W; Gamache P; Aronin N
    Anesth Prog; 1992; 39(6):201-8. PubMed ID: 7504420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid studies of monoamine metabolism in schizophrenia.
    van Kammen DP; Peters J; van Kammen WB
    Psychiatr Clin North Am; 1986 Mar; 9(1):81-97. PubMed ID: 2421272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl.
    Martignoni E; Bono G; Blandini F; Sinforiani E; Merlo P; Nappi G
    J Neural Transm Park Dis Dement Sect; 1991; 3(1):15-25. PubMed ID: 1712206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoamine metabolism and sympathetic nervous activation following subarachnoid haemorrhage: influence of gender and hydrocephalus.
    Lambert G; Naredi S; Edén E; Rydenhag B; Friberg P
    Brain Res Bull; 2002 May; 58(1):77-82. PubMed ID: 12121816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concentrations of cerebrospinal fluid monoamine metabolites in suicides.
    Lester D
    Psychol Rep; 1991 Feb; 68(1):146. PubMed ID: 1709746
    [No Abstract]   [Full Text] [Related]  

  • 32. Dopamine, noradrenaline and serotonin spinal fluid metabolites in temporal lobe epileptic patients with schizophrenic symptomatology.
    Peters JG
    Eur Neurol; 1979; 18(1):15-8. PubMed ID: 436860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurochemical changes in pigeon cerebrospinal fluid during chronic administration of buspirone or 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Nader MA; Barrett JE
    Pharmacol Biochem Behav; 1989 Jan; 32(1):227-32. PubMed ID: 2471984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in 5-HIAA and 5-HT levels in lumbar CSF following morphine administration to conscious dogs.
    Bardon T; Ruckebusch M
    Neurosci Lett; 1984 Aug; 49(1-2):147-51. PubMed ID: 6208513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoamine interactions in narcolepsy and hypersomnia: a preliminary report.
    Faull KF; Thiemann S; King RJ; Guilleminault C
    Sleep; 1986; 9(1 Pt 2):246-9. PubMed ID: 2422716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between high-performance liquid chromatography and automated fluorimetric methods for the determination of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindoleacetic acid in nervous tissue and cerebrospinal fluid.
    Westerink BH
    J Chromatogr; 1982 Dec; 233():69-77. PubMed ID: 6186680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
    Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
    Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diazepam and atropine as premedicants: no discrimination by monoamine metabolite and catecholamine measurements in cerebrospinal fluid and plasma.
    Kanto J; Scheinin M
    Acta Anaesthesiol Scand; 1992 Jan; 36(1):80-3. PubMed ID: 1371633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoamine neurotransmitters and their metabolites in the mature rabbit brain following induction of hydrocephalus.
    Del Bigio MR; Bruni JE; Vriend JP
    Neurochem Res; 1998 Nov; 23(11):1379-86. PubMed ID: 9814548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral blood gene expression profiles linked to monoamine metabolite levels in cerebrospinal fluid.
    Luykx JJ; Olde Loohuis LM; Neeleman M; Strengman E; Bakker SC; Lentjes E; Borgdorff P; van Dongen EP; Bruins P; Kahn RS; Horvath S; de Jong S; Ophoff RA
    Transl Psychiatry; 2016 Dec; 6(12):e983. PubMed ID: 27959337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.